STAT1 alpha Recombinant Rabbit Monoclonal Antibody [SJ01-89]
Overview
Product Name
STAT1 alpha Recombinant Rabbit Monoclonal Antibody [SJ01-89]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within human STAT1 aa 710-750.
Product Specificity
Stat1 [SJ01-89] Recombinant Rabbit mAb recognizes endogenous levels of total Stat1 alpha protein.
Species Reactivity
Human, Mouse
Validated Applications
WB, IP, FC, IHC-P, IF-Cell, IF-Tissue
Molecular Weight
Predicted band size: 87 kDa
Positive Control
Jurkat cell lysate, A431 cell lysate, HeLa cell lysate, A549 cell lysate, SK-Br-3 cell lysate, SK-MEL-28 cell lysate, HT-29 cell lysate, RAW264.7 cell lysate, C2C12 cell lysate, human kidney tissue, human colon tissue, human ovary cancer tissue, human spleen tissue, mouse colon tissue, HeLa, RAW264.7.
Conjugation
unconjugated
Clone Number
SJ01-89
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000-1:5,000
-
FC
-
1:100
-
IP
-
Use at an assay dependent concentration.
-
IHC-P
-
1:500-1:5,000
-
IF-Cell
-
1:100
-
IF-Tissue
-
1:50-1:400
Target
Function
Membrane receptor signaling by various ligands, including interferons and growth hormones such as EGF, induces activation of JAK kinases which then leads to tyrosine phosphorylation of the various Stat transcription factors. Stat1 and Stat2 are induced by IFN-α and form a heterodimer which is part of the ISGF3 transcription factor complex. Although early reports indicate Stat3 activation by EGF and IL-6, it has been shown that Stat3β appears to be activated by both while Stat3α is activated by EGF, but not by IL-6. Highest expression of Stat4 is seen in testis and myeloid cells. IL-12 has been identified as an activator of Stat4. Stat5 has been shown to be activated by Prolactin and by IL-3. Stat6 is involved in IL-4 activated signaling pathways. Mutations in the STAT1 molecule can be gain of function (GOF) or loss of function (LOF). Both of them can cause different phenotypes and symptoms. Recurring common infections are frequent in both GOF and LOF mutations. In humans STAT1 has been particularly under strong purifying selection when populations shifted from hunting and gathering to farming, because this went along with a change in the pathogen spectrum. STAT1 loss of function, therefore STAT1 deficiency can have many variants. There are two main genetic impairments that can cause response to interferons type I and III. First there can be autosomal recessive partial or even complete deficiency of STAT1. That causes intracellular bacterial diseases or viral infections and impaired IFN a, b, g and IL27 responses are diagnosed. In partial form there can also be found high levels of IFNg in blood serum. When tested from whole blood, monocytes do not respond to BCG and IFNg doses with IL-12 production. In complete recessive form there is a very low response to anti-viral and antimycotical medication. Second, partial STAT1 deficiency can also be an autosomal dominant mutation; phenotypically causing impaired IFNg responses and causing patients to suffer with selective intracellular bacterial diseases (MSMD).
Background References
1. Shakya R et al. Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. Cancer Res 73:885-96 (2013).
2. Syu LJ et al. Transgenic expression of interferon- in mouse stomach leads to inflammation, metaplasia, and dysplasia. Am J Pathol 181:2114-25 (2012).
Sequence Similarity
Belongs to the transcription factor STAT family.
Post-translational Modification
Phosphorylated on tyrosine and serine residues in response to a variety of cytokines/growth hormones including IFN-alpha, IFN-gamma, PDGF and EGF. Activated KIT promotes phosphorylation on tyrosine residues and subsequent translocation to the nucleus. Upon EGF stimulation, phosphorylation on Tyr-701 (lacking in beta form) by JAK1, JAK2 or TYK2 promotes dimerization and subsequent translocation to the nucleus. Growth hormone (GH) activates STAT1 signaling only via JAK2. Tyrosine phosphorylated in response to constitutively activated FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylation on Ser-727 by several kinases including MAPK14, ERK1/2 and CAMKII on IFN-gamma stimulation, regulates STAT1 transcriptional activity. Phosphorylation on Ser-727 promotes sumoylation though increasing interaction with PIAS. Phosphorylation on Ser-727 by PRKCD induces apoptosis in response to DNA-damaging agents. Phosphorylated on tyrosine residues when PTK2/FAK1 is activated; most likely this is catalyzed by a SRC family kinase. Dephosphorylation on tyrosine residues by PTPN2 negatively regulates interferon-mediated signaling. Upon viral infection or IFN induction, phosphorylation on Ser-708 occurs much later than phosphorylation on Tyr-701 and is required for the binding of ISGF3 on the ISREs of a subset of IFN-stimulated genes IKBKE-dependent. Phosphorylation at Tyr-701 and Ser-708 are mutually exclusive, phosphorylation at Ser-708 requires previous dephosphorylation of Tyr-701.; Sumoylated with SUMO1, SUMO2 and SUMO3. Sumoylation is enhanced by IFN-gamma-induced phosphorylation on Ser-727, and by interaction with PIAS proteins. Enhances the transactivation activity.; ISGylated.; Mono-ADP-ribosylated at Glu-657 and Glu-705 by PARP14; ADP-ribosylation prevents phosphorylation at Tyr-701. However, the role of ADP-ribosylation in the prevention of phosphorylation has been called into question and the lack of phosphorylation may be due to sumoylation of Lys-703.; Monomethylated at Lys-525 by SETD2; monomethylation is necessary for phosphorylation at Tyr-701, translocation into the nucleus and activation of the antiviral defense.
Subcellular Location
Cytoplasm, Nucleus.
Synonyms
Signal transducer and activator of transcription 1 91kD antibody
CANDF7 antibody
DKFZp686B04100 antibody
IMD31A antibody
IMD31B antibody
IMD31C antibody
ISGF 3 antibody
ISGF-3 antibody
OTTHUMP00000163552 antibody
OTTHUMP00000165046 antibody
ExpandSignal transducer and activator of transcription 1 91kD antibody
CANDF7 antibody
DKFZp686B04100 antibody
IMD31A antibody
IMD31B antibody
IMD31C antibody
ISGF 3 antibody
ISGF-3 antibody
OTTHUMP00000163552 antibody
OTTHUMP00000165046 antibody
OTTHUMP00000165047 antibody
OTTHUMP00000205845 antibody
Signal transducer and activator of transcription 1 91kDa antibody
Signal transducer and activator of transcription 1 antibody
Signal transducer and activator of transcription 1, 91kD antibody
Signal transducer and activator of transcription 1-alpha/beta antibody
STAT 1 antibody
Stat1 antibody
STAT1_HUMAN antibody
STAT91 antibody
Transcription factor ISGF 3 components p91 p84 antibody
Transcription factor ISGF-3 components p91/p84 antibody
CollapseImages
-
Western blot analysis of STAT1 alpha on different lysates with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/1,000 dilution.
Lane 1: Jurkat cell lysate
Lane 2: A431 cell lysate
Lane 3: HeLa cell lysate
Lane 4: A549 cell lysate
Lane 5: SK-Br-3 cell lysate
Lane 6: SK-MEL-28 cell lysate
Lane 7: HT-29 cell lysate
Lane 8: RAW264.7 cell lysate
Lane 9: C2C12 cell lysate
Lysates/proteins at 15 µg/Lane.
Predicted band size: 87 kDa
Observed band size: 87 kDa
Exposure time: 14 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1606-39) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of STAT1 alpha on different lysates with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/5,000 dilution.
Lane 1: HAP1-parental cell lysate, 10 µg/Lane
Lane 2: HAP1-STAT1 alpha KD cell lysate, 10 µg/Lane
Predicted band size: 87 kDa
Observed band size: 87 kDa
Exposure time: 60 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1606-39) at 1/5,000 dilution was used in K1803 at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-39) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human colon tissue with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-39) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human ovary cancer tissue with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-39) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human spleen tissue with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-39) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse colon tissue with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-39) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunocytochemistry analysis of RAW264.7 cells labeling STAT1 alpha with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of RAW264.7 cells labeling STAT1 alpha.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1606-39, 1/100) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Immunocytochemistry analysis of HeLa cells labeling STAT1 alpha with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-STAT1 alpha antibody (ET1606-39) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
AARS1-mediated lactylation of STAT1 drives immune evasion
Journal: Cell Reports
DOI: 10.1016/j.celrep.2026.117094
IF: 6.9
Application: WB,IP,IHC
Reactivity: Mouse,Human
Publish date: 2026 Mar
-
Curcuminoids amplify host innate antiviral immunity via the CRYAB-RBM26 axis in viral infection
Journal: iMeta Science
DOI: 10.1002/imt2.70111
IF: 33.2
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner
Journal: Cell Death & Disease
DOI:
IF: 8.1
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner
Journal: Cell Death & Disease
DOI: 10.1038/s41419-025-07341-5
IF: 9.6
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
tRF-21LeuTAA Promotes Oxidative Stress by Altering Glutathione Metabolic Enzymes to Support Prostate Cancer Progression
Journal: Cancer Research
DOI: 10.1158/0008-5472.CAN-25-0273
IF: 16.6
Application: WB
Reactivity: Human
Publish date: 2025 Aug
-
In vitro and in vivo study of concentrated growth factor (CGF) mediating macrophage polarization in bone defect repair
Journal: Regenerative Therapy
DOI: 10.1016/j.reth.2025.04.013
IF: 3.4
Application: WB
Reactivity: Human
Publish date: 2025 Apr
-
MicroRNA-122 protects against interferon-α-induced hepatic inflammatory response via the Janus kinase–signal transducer and activator of transcription pathway
Journal: Endocrine Journal
DOI:
IF: 1.3
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
Reduced Proline-Rich Tyrosine Kinase 2 Promotes Tumor Metastasis by Activating Epithelial–Mesenchymal Transition in Colorectal Cancer
Journal: Digestive Diseases And Sciences
DOI:
IF: 2.5
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
Environmentally related microcystin-LR-induced ovarian dysfunction via the CCL2-CCR10 axis in mice ameliorated by dietary mulberry
Journal: Environmental Pollution
DOI:
IF: 7.6
Application: WB
Reactivity: Mouse
Publish date: 2024 May
-
Inhibit of the cGAS-STING-STAT1 pathway protects heart from the Doxorubicin-induced cardiotoxicity
Journal: Preprint And Has Not Been Certified By Peer Review
DOI:
IF:
Application: WB
Reactivity: Mouse
Publish date: 2024 Jun
-
IMPDH inhibitors upregulate PD-L1 in cancer cells without impairing immune checkpoint inhibitor efficacy
Journal: Acta Pharmacologica Sinica
DOI:
IF: 6.9
Application: WB
Reactivity: Mouse
Publish date: 2024 Dec
-
Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer
Journal: Biomedicine & Pharmacotherapy
DOI:
IF: 7.419
Application: WB
Reactivity: Human,Mouse
Publish date: 2022 Nov
-
Bafetinib Suppresses the Transcription of PD-L1 Through c-Myc in Lung Cancer
Journal: Frontiers In Pharmacology
DOI:
IF: 5.811
Application: WB
Reactivity: Human
Publish date: 2022 Jun
-
A 2-Benzylmalonate Derivative as STAT3 Inhibitor Suppresses Tumor Growth in Hepatocellular Carcinoma by Upregulating β-TrCP E3 Ubiquitin Ligase. International journal of molecular sciences, 22(7), 3354.
Journal: International Journal Of Molecular Sciences
DOI:
IF:
Application: WB
Reactivity: Mouse
Publish date: 2021 Mar
-
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma. Frontiers in cell and developmental biology, 9, 689727.
Journal: Frontiers In Cell And Developmental Biology
DOI:
IF: 6.684
Application: WB
Reactivity: Mouse
Publish date: 2021 Jul
-
Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3
Journal: Cell Death & Disease
DOI:
IF: 5.64
Application: Co-IP
Reactivity: Human
Publish date: 2019 Feb
Products with the same target and pathway
STAT1 alpha Recombinant Rabbit Monoclonal Antibody [SJ01-89] - BSA and Azide free
Application: WB,IP,FC,IHC-P,IF-Cell,IF-Tissue
Reactivity: Human,Mouse
Conjugate: unconjugated